login
login

Europe Daily Bulletin No. 12836

20 November 2021
Contents Publication in full By article 20 / 31
EU RESPONSE TO COVID-19 / Health
European Medicines Agency publishes opinion on emergency use of Merck’s Covid-19 treatment candidate
Brussels, 19/11/2021 (Agence Europe)

As announced at the beginning of the month, the European Medicines Agency (EMA) issued an opinion on Friday 19 November on the emergency use of Lagevrio (molnupiravir or MK 4482), the candidate treatment against Covid-19 that has been developed by the Merck laboratory (see EUROPE B12829A23).

This drug, which has now been under evaluation by the EMA for almost a month, has not yet been granted a European marketing authorisation.

However, since the health situation in the EU is particularly...

Contents

SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
COUNCIL OF EUROPE
NEWS BRIEFS